
Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer
Here’s what you missed: Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April, May and June, featuring expert …